Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm
Mandate

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm

May 09, 2011

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm and Nordic Capital's offering of shares in connection therewith. Expected start of trading is on May 20, 2011. Handelsbanken Capital Markets and Carnegie Investment Bank are Joint Lead Managers and Joint Book Runners in the offering.

Vinge's project team is composed primarily of Göran Nyström, Pontus Enquist, Dain Nevonen and Christoffer Benninge as well as Lennart Larsson and Lina Hansson regarding tax matters.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025